A theranostic endoperoxide agent with targeted singlet oxygen release and concomitant fluorescence signals
Abstract
levels in cancer cells, the phenylboronic ester undergoes specific cleavage to generate hydroxyl groups. This structural transformation triggers a blue-to-green fluorescence emission change, providing direct visual confirmation of therapeutic activation within the tumor microenvironment.
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Molecular Sensors and Ion Detection
Photodynamic Therapy Research Studies
Publication details
- Journal / source
- Journal of Materials Chemistry B
- Volume
- 14
- Issue
- 8
- Pages
- 2438–2449
- Publication date
- 1 January 2026
- Language
- EN